| JXSL2300210 | 注射用重组单链人凝血因子VIII | | Lyophilized | Biological Products(3.1) | Import Drug Application | 2023-11-28 | | | | | view |
| JTS2200020 | 注射用重组人凝血因子Ⅷ | Recombinant Coagulation Factor Ⅷ | Lyophilized | Biological Products | Disposable Import Drug Application | 2022-04-20 | | | | | view |
| JYSB2101169 | 注射用重组人凝血因子VIII | Recombinant Coagulation Factor Ⅷ | Lyophilized | Biological Products | Supplementary Application | 2021-11-25 | | | | | view |
| CYSB2400133 | 注射用重组人凝血因子Ⅷ | Recombinant Coagulation Factor Ⅷ | Lyophilized | Biological Products(原10) | Supplementary Application | 2024-05-24 | | SinoCelltech Ltd | | | view |
| JYSZ2100536 | 注射用重组人凝血因子Ⅷ | Recombinant Coagulation Factor Ⅷ | Lyophilized | Biological Products | License Renew | 2021-12-17 | | | | | view |
| CYSB2200148 | 人凝血因子Ⅷ | Recombinant Coagulation Factor Ⅷ | Lyophilized | Biological Products | Supplementary Application | 2022-06-08 | | Shanghai RAAS Blood Products Co Ltd | | | view |
| JTS2400104 | 注射用培重组人凝血因子VIII | | | Biological Products | Disposable Import Drug Application | 2024-09-25 | | | | | view |
| JYSB2200143 | 注射用重组人凝血因子Ⅷ | Recombinant Coagulation Factor Ⅷ | Lyophilized | Biological Products | Supplementary Application | 2022-08-08 | | Bayer Healthcare LLC | | | view |
| JXSS2200005 | 注射用重组人凝血因子VIII | Recombinant Coagulation Factor Ⅷ | Lyophilized | Biological Products(3.1) | Import Drug Application | 2022-01-26 | | | | | view |
| JYSB2400155 | 注射用重组人凝血因子Ⅷ | Recombinant Coagulation Factor Ⅷ | Lyophilized | Biological Products | Supplementary Application | 2024-07-16 | | | | | view |
| JYSZ2200049 | 注射用重组人凝血因子Ⅷ | Recombinant Coagulation Factor Ⅷ | Lyophilized | Biological Products | License Renew | 2022-09-14 | | | | | view |
| CXSL2300026 | 人凝血因子Ⅷ | Recombinant Coagulation Factor Ⅷ | Lyophilized | Biological Products(3.4) | New Drug Application | 2023-01-11 | | Sichuan Yuanda Shuyang Pharmaceutical Co Ltd | | | view |
| JYSB2200145 | 注射用重组人凝血因子Ⅷ | Recombinant Coagulation Factor Ⅷ | Lyophilized | Biological Products | Supplementary Application | 2022-08-08 | | Bayer Healthcare LLC | | | view |
| JXSL2300213 | 注射用重组单链人凝血因子VIII | | Lyophilized | Biological Products(3.1) | Import Drug Application | 2023-11-28 | | | | | view |
| JYSB2200164 | 注射用重组人凝血因子Ⅷ | Recombinant Coagulation Factor Ⅷ | Lyophilized | Biological Products | Supplementary Application | 2022-08-24 | | Bayer Healthcare LLC | | | view |
| JYSB2400182 | 注射用重组人凝血因子VIII | Recombinant Coagulation Factor Ⅷ | Lyophilized | Biological Products | Supplementary Application | 2024-08-14 | | | | | view |
| JYSB2101163 | 注射用重组人凝血因子VIII | Recombinant Coagulation Factor Ⅷ | Lyophilized | Biological Products | Supplementary Application | 2021-11-10 | | | | | view |
| CXSB2300105 | 注射用培重组人凝血因子VIII-Fc融合蛋白 | | Lyophilized | Biological Products(1) | Supplementary Application | 2023-10-11 | | Jiangsu Shengsi Biopharmaceutical Co Ltd | | | view |
| JYSB2200065 | 注射用重组人凝血因子Ⅷ | Recombinant Coagulation Factor Ⅷ | Lyophilized | Biological Products | Supplementary Application | 2022-04-08 | | Novo Nordisk A/S | | | view |
| CXSS2200013 | 注射用重组人凝血因子Ⅷ | Recombinant Coagulation Factor Ⅷ | Lyophilized | Biological Products(3.4) | New Drug Application | 2022-02-07 | | Nanjing Shunxin Pharmaceuticals Co LTDof Chiatai Tianqing Pharmaceutical Group | | | view |
